Reactions 1680, p334 - 2 Dec 2017 Leucopenia and neutropenia: case report A patient [age and sex not stated] developed leucopenia and neutropenia during treatment with venlafaxine [dosage, route, indication, time to reactions onsets and outcomes not stated]. Author comment: "We here report a case of a patient who experienced leukopenia and neutropenia after initiating treatment with venlafaxine. To the best of our knowledge, there are two published case reports in which venlafaxaine was possibly causing a decrease in WBC and/or neutrophil count." Mojica-Rangel M, et al. Venlafaxine induced neutropenia. CNS Spectrums 21: 98, No. 1, Feb 2016. Available from: URL: http://doi.org/10.1017/ S1092852915000905 [Abstract] - USA 803284800 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera